Let me just speak to one area. We talked about dementia. We talked about the very important work of the Alzheimer Society, and they play a very important leadership role in understanding the impact of dementia and loss of cognitive abilities. The reality is that in MS there are also associated issues of cognitive loss and depression.
These questions about those impacts--impacts obviously in terms of personal quality of life, impact on the family unit, on caregivers--are common. You'll readily see that while in MS, it is not one of the symptoms we will speak about first--we'll speak about fatigue, loss of mobility, loss of sight--these other symptoms are also real for many people. That's where those parallels are very important.
For instance, if you think of research on models of care other than the biomedical research, the commonalities there are just incredibly promising in terms of advancing approaches to housing, to our health system, the delivery of services. That's just one example.
There are many examples, including obviously some approaches that are about the medical aspects. Stem cell research has the opportunity to regenerate lost nerves in Parkinson's, in Alzheimer's, and in MS. In this city, there have been experimental treatments in stem cell research. There is lots of excitement about those avenues. There's another area of potential collaboration. We're really excited about the collaboration across the major neurological health charities.
